Wird geladen...
Long‐term safety of brodalumab in Japanese patients with plaque psoriasis: An open‐label extension study
Brodalumab, an interleukin‐17 receptor A inhibitor, demonstrated rapid and robust efficacy with a favorable safety profile in patients with moderate to severe plaque psoriasis. Here, we present data from a multicenter, open‐label extension study in patients with plaque psoriasis with/without psoriat...
Gespeichert in:
| Veröffentlicht in: | J Dermatol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7318217/ https://ncbi.nlm.nih.gov/pubmed/32275086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1346-8138.15343 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|